We recognize the challenges inherent in identifying the most promising hit for your target and we tackle them by developing and validating meaningful primary assays and robust confirmation/validation tools. Our team can deploy robust screening tools, including high-throughput screening technology on a 350,000-compound library, to ensure your project advances quickly. Our experience also enables us to tackle hit identification in particularly challenging targets, where our competitors may have been unsuccessful.

Our Offering:

  • Pilot screening to validate output of full high-throughput screening campaign;
  • Virtual screening;
  • High-throughput screening (HTS) campaigns;
  • Proprietary, curated compound library with 350,000 compounds;
  • Compound library hosting and screening through a fully automated system;
  • Screening platform with multiple detection technologies;
  • Proprietary phage display libraries for peptide and biologics discovery;
  • Protein and peptide production;
  • Knowledge-based design;
  • NMR-driven fragment-based approaches;
  • Preliminary structure-activity relationship (SAR) acquisition;
  • Protein-ligand interaction studies by NMR;
  • Kinetic/thermodynamic binding studies.